WallStreetZenWallStreetZen

NASDAQ: ACLX
Arcellx Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ACLX

Based on 3 analysts offering 12 month price targets for Arcellx Inc

Min Forecast
$110.00+54.32%
Avg Forecast
$119.33+67.41%
Max Forecast
$133.00+86.59%

Should I buy or sell ACLX stock?

Based on 3 analysts offering ratings for Arcellx Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ACLX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ACLX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ACLX stock forecasts and price targets.

ACLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-06-17
lockedlocked$00.00+00.00%2025-06-16

1 of 1

Forecast return on equity

Is ACLX forecast to generate an efficient return?

Company
-3.21%
Industry
124.07%
Market
-49.12%
ACLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACLX forecast to generate an efficient return on assets?

Company
-2.06%
Industry
47.18%
ACLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACLX earnings per share forecast

What is ACLX's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$3.91
Avg 2 year Forecast
-$3.07
Avg 3 year Forecast
-$2.27

ACLX revenue forecast

What is ACLX's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$57.7M-24.88%
Avg 2 year Forecast
$157.7M+105.32%
Avg 3 year Forecast
$279.4M+263.74%
ACLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACLX revenue growth forecast

How is ACLX forecast to perform vs Biotechnology companies and vs the US market?

Company
53.13%
Industry
78.36%
Market
10.83%
ACLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACLX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACLX$71.28$119.33+67.41%Strong Buy
AKRO$49.23$73.25+48.79%Strong Buy
PTCT$50.57$71.08+40.56%Strong Buy
ZLAB$35.04$57.22+63.30%Buy
TLX$12.48$22.50+80.29%Buy
View Top Biotech Stocks

Arcellx Stock Forecast FAQ

Is Arcellx Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ACLX) stock is to Strong Buy ACLX stock.

Out of 3 analysts, 1 (33.33%) are recommending ACLX as a Strong Buy, 2 (66.67%) are recommending ACLX as a Buy, 0 (0%) are recommending ACLX as a Hold, 0 (0%) are recommending ACLX as a Sell, and 0 (0%) are recommending ACLX as a Strong Sell.

If you're new to stock investing, here's how to buy Arcellx stock.

What is ACLX's earnings growth forecast for 2025-2027?

(NASDAQ: ACLX) Arcellx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.31%.

Arcellx's earnings in 2025 is -$162,420,000.On average, 9 Wall Street analysts forecast ACLX's earnings for 2025 to be -$215,649,061, with the lowest ACLX earnings forecast at -$249,082,298, and the highest ACLX earnings forecast at -$164,217,975. On average, 9 Wall Street analysts forecast ACLX's earnings for 2026 to be -$169,177,578, with the lowest ACLX earnings forecast at -$263,410,040, and the highest ACLX earnings forecast at -$40,227,893.

In 2027, ACLX is forecast to generate -$124,871,789 in earnings, with the lowest earnings forecast at -$263,961,107 and the highest earnings forecast at -$49,044,966.

What is ACLX's revenue growth forecast for 2025-2027?

(NASDAQ: ACLX) Arcellx's forecast annual revenue growth rate of 53.13% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 78.36%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Arcellx's revenue in 2025 is $76,809,000.On average, 5 Wall Street analysts forecast ACLX's revenue for 2025 to be $3,179,491,443, with the lowest ACLX revenue forecast at $1,697,286,452, and the highest ACLX revenue forecast at $5,055,764,467. On average, 5 Wall Street analysts forecast ACLX's revenue for 2026 to be $8,690,547,490, with the lowest ACLX revenue forecast at $5,466,584,938, and the highest ACLX revenue forecast at $15,836,233,668.

In 2027, ACLX is forecast to generate $15,396,041,324 in revenue, with the lowest revenue forecast at $11,897,537,178 and the highest revenue forecast at $17,926,210,486.

What is ACLX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ACLX) forecast ROA is -2.06%, which is lower than the forecast US Biotechnology industry average of 47.18%.

What is ACLX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ACLX price target, the average ACLX price target is $119.33, with the highest ACLX stock price forecast at $133.00 and the lowest ACLX stock price forecast at $110.00.

On average, Wall Street analysts predict that Arcellx's share price could reach $119.33 by Jul 31, 2026. The average Arcellx stock price prediction forecasts a potential upside of 67.41% from the current ACLX share price of $71.28.

What is ACLX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ACLX) Arcellx's current Earnings Per Share (EPS) is -$2.99. On average, analysts forecast that ACLX's EPS will be -$3.91 for 2025, with the lowest EPS forecast at -$4.52, and the highest EPS forecast at -$2.98. On average, analysts forecast that ACLX's EPS will be -$3.07 for 2026, with the lowest EPS forecast at -$4.78, and the highest EPS forecast at -$0.73. In 2027, ACLX's EPS is forecast to hit -$2.27 (min: -$4.79, max: -$0.89).

What is ACLX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ACLX) forecast ROE is -3.21%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.